Margherita Razzoli

ETH Zurich

Papers

1

Total Citations

3

H-Index

1

About

Margherita Razzoli is a leading researcher in neurorehabilitation, with a focus on restoring function in individuals with upper-limb spasticity following central nervous system lesions. Her work bridges pharmacological intervention and cutting-edge robotics, most notably through her pilot study on the feasibility of combining botulinum neurotoxin type A (BoNT-A) injections with a robotic hand orthosis. This landmark 2024 paper, already garnering 3 citations, addresses a critical clinical gap: while BoNT-A effectively reduces muscle tone and increases range of motion, post-injection physical therapy is often hindered by residual weakness. Razzoli’s innovative protocol demonstrates how robotic assistance can safely enable early, targeted rehabilitation, maximizing the therapeutic window of BoNT-A. Her contributions are reshaping standard care for spasticity, offering a scalable, patient-centered approach that enhances motor recovery. With a growing portfolio of translational work, Razzoli is recognized for her ability to integrate clinical practicality with advanced technology, making her a pivotal figure in modern neurorehabilitation. Her research not only advances scientific understanding but directly improves quality of life for patients with chronic neurological conditions.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Feasibility of Adjunct Therapy with a Robotic Hand Orthosis after Botulinum Toxin Injections in Persons with Spasticity: A Pilot Study
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: ETH Zurich

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago